doi: 10.1503/cmaj.109-4378.
Epub 2012 Dec 17.
Cochrane review questions value of industry-funded clinical trials
- PMID: 23251018
- PMCID: PMC3563897
- DOI: 10.1503/cmaj.109-4378
Item in Clipboard
Cochrane review questions value of industry-funded clinical trials
CMAJ.
.
No abstract available
Figures
The persistence of bias in company-sponsored clinical trials is a growing cause for concern because industry’s influence is increasing.
Similar articles
-
Drug industry misses target for funding work on campus.Science. 1997 Jan 3;275(5296):23-4. doi: 10.1126/science.275.5296.23. Science. 1997. PMID: 8999528 No abstract available.
-
Industry sponsorship in research and publishing: who is really to blame for perceived bias?Ann Pharmacother. 2004 Apr;38(4):714-6. doi: 10.1345/aph.1D617. Epub 2004 Feb 24. Ann Pharmacother. 2004. PMID: 14982974 No abstract available.
-
Non-drug industry funded research.BMJ. 2008 Jan 5;336(7634):1-2. doi: 10.1136/bmj.39416.559942.BE. Epub 2007 Dec 6. BMJ. 2008. PMID: 18063610 Free PMC article.
-
Industry funding effect on positive results of probiotic use in the management of acute diarrhea: a systematized review.Eur J Gastroenterol Hepatol. 2019 Mar;31(3):289-302. doi: 10.1097/MEG.0000000000001322. Eur J Gastroenterol Hepatol. 2019. PMID: 30557228
-
Industry sponsorship and authorship of clinical trials over 20 years.Ann Pharmacother. 2004 Apr;38(4):579-85. doi: 10.1345/aph.1D267. Epub 2004 Feb 24. Ann Pharmacother. 2004. PMID: 14982982 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
